News and Events

Keep up-to-date on recent events, webinars and releases from ArcherDX.



Jul
19
2016

Characterizing hematologic malignancies with ArcherDX blood cancer assays

This webinar will review multiple applications ArcherDX® FusionPlex® and VariantPlex™ blood cancer assays to address the significant clinical implications in the diagnosis and management of hematologic malignancies.


Jul
9
2016

ArcherDX at EACR24

Going to EACR24? Join ArcherDX for in-booth presentations on ArcherDX’s exciting FusionPlex products and bioinformatics analysis tools. Presentations will be hosted by ArcherDX in booth D470.


Jun
3
2016

ArcherDX at ASCO 2016

Join us at the ASCO Annual Meeting 2016 in Chicago, Illinois from June 3-7, 2016. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer® is unleashing the power of translational NGS to enable mutation detection.


May
31
2016

ArcherDX to collaborate with Illumina on NGS-based in vitro diagnostics development

ArcherDX will lead development of diagnostic tests powered by Anchored Multiplex PCR (AMP™) enrichment chemistry that will run on the Illumina® MiSeq® sequencing instrument


May
21
2016

European Human Genetics Conference 2016

Join us for the 2016 European Human Genetics Conference in Barcelona, Spain from May 21-24. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


May
12
2016

Developing and validating an ALK, ROS1, RET RNA fusion reference standard for targeted NGS

This webinar will detail the need for accurate and consistent fusion reference standards and how Horizon Discovery and ArcherDX partnered to develop the Archer™ SureShot™ ALK, RET, ROS1 standards.


Apr
16
2016

Archer announces Research Challenge Grant

Archer will award 5 recipients up to 192 free reactions (24 kits with 8 reactions each) of an Archer Assay of their choosing and training from our expert Field Applications Specialists.


Apr
16
2016

New Archer Blood Cancer NGS Assays announced at AACR 2016

Join us for AACR 2016 in New Orleans, LA from April 16-20. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Apr
6
2016

Next Generation Sequencing Applications and Sample Prep Workflow Improvements

This webinar will detail the advantages of gene fusion detection via RNA-Seq methods and enhancements that can be gained through improvements in nucleic acid purification protocols.


Apr
3
2016

ArcherDX at the 13th International Congress of Human Genetics (ICHG)

Join us for the International Congress of Human Genetics in Kyoto, Japan from April 3-7, 2016. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Mar
12
2016

New Archer options revealed at USCAP 2016 Annual Meeting

Join us for the USCAP 2016 Annual Meeting in Seattle, WA from March 12-18. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Dec
2
2015

What's new in Archer Analysis 4.0?

See what's new in Archer Analysis 4.0. This update introduces many new features and enhancements, such as fusion visualization, RNA abundance, DNA variant filtering, user management and cloud options.


Nov
5
2015

Association of Molecular Pathology Annual Meeting 2015

Join us for the annual Association of Molecular Pathology Meeting in Austin, TX. By combining revolutionary Anchored Multiplex PCR chemistry with an easy-to-use workflow and intuitive software, Archer is unleashing the power of translational NGS to enable accurate and scalable mutation detection.


Oct
12
2015

ArcherDX Launches NGS Solution for Comprehensive Lung and Thyroid Tumor Profiling

The Archer™ Comprehensive Thyroid and Lung (CTL) Assay combines two complementary targeted NGS panels to detect gene fusions, point mutations, RNA abundance and copy number variations (CNVs) from FFPE and FNA lung and thyroid cancer samples.


Sep
29
2015

ArcherDX and BioChain to Provide NGS-characterized FFPE Tumor Samples

BioChain will supply ArcherDX with multiple types of tumor FFPE samples, including NSCLC samples, which will be comprehensively screened for oncogenic fusions, copy number variations (CNVs), single nucleotide variants (SNVs) and insertions/deletions (indels) using the Archer VariantPlex™ and FusionPlex™ Solid Tumor assays.


Sep
18
2015

Clinically actionable gene fusions, CNVs and SNVs detected by NGS-based comprehensive tumor profiling

Dr. A. John Iafrate, MD PhD discusses the practical challenges of clinical genotyping and how next-generation sequencing (NGS) and Anchored Multiplex PCR (AMP) technologies address those challenges in the clinic.


Aug
28
2015

Evolution of NGS-based detection of fusions, SNVs and CNVs using Anchored Multiplex PCR

Brian Kudlow, PhD, discusses the challenges of cancer genomics and how Archer technology addresses those challenges in the laboratory. Dr. Kudlow also discuss what Archer technology is moving towards in the future.


Jul
16
2015

Archer Analysis Software Webinar by Thon deBoer

New features discussed include the ability to probe DNA/RNA mutations and enumerate copy number variations, graphical metrics output, and better progress indications


Jun
23
2015

Dr. Kudlow speaks at Festival of Genomics, 2015

Seminar: Comprehensive tumor profiling: a targeted approach using purpose-built technology


May
29
2015

Meet the next-gen variant detection experts at ASCO 2015

To address the existing bottlenecks of using NGS in translational research, we’ve created a line of innovative products that are purpose-built for clinical oncology research. Learn how Archer™ NGS assays are revolutionizing RNA/DNA analysis.


May
22
2015

Beyond Fusions - Webinar by Josh Stahl

Josh Stahl, Vice-President of R&D and Scientific Operations at ArcherDX, describes the benefits of AMP chemistry and how it is best suited for DNA-based mutation detection. He will also discuss how Archer VariantPlex assays detect CNVs from DNA, and how combining FusionPlex and VariantPlex assays maximizes mutation detection from a single FFPE sample.


May
20
2015

Archer Analysis updated to version 3.2

Archer Analysis has been updated to version 3.2 to include support for CNV detection via Archer VariantPlex DNA panels and printable analysis reports.


Mar
10
2015

Identifying translocations in solid tumors: Webinar by Brady Culver, PhD

Brady Culver, PhD, Senior R&D Manager and Lead Scientist at ArcherDX, describes the challenges of gene fusions discovery in solid tumors and his process for developing and characterizing a comprehensive NGS panel to assess translocations in these tumor types.


Feb
25
2015

Archer assays are purpose-built for revolutionary mutation calling - Learn more at AGBT, 2015

To address the existing bottlenecks of using NGS in translational research, we’ve created a line of innovative products that are purpose-built for clinical oncology research. Learn how Archer™ NGS assays are revolutionizing RNA/DNA analysis.


Feb
17
2015

Change is not coming. Change is here. See ArcherDX at TriCon 2015

Join us at Molecular Medicine Tri-Conference 2015 to learn about how Archer™ FusionPlex™ Assays are bridging the gap between NGS and scalable, accurate and comprehensive gene fusion detection.

Subscribe to stay in the loop







How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.